Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Investigation of the PELSA Microneedle-Based Device for Dermal Interstitial Fluid Sampling in Healthy Adults: Assessment of Performance and Safety

NCT07882225 is registered in ClinicalTrials.gov with Ascilion AB as lead sponsor.

NCT NCT07882225
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07882225 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Investigation of the PELSA Microneedle-Based Device for Dermal Interstitial Fluid Sampling in Healthy Adults: Assessment of Performance and Safety
Lead sponsor
Ascilion AB
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
February 28, 2027
Enrollment
110 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dermal interstitial fluid sampling